Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Justine, Boles"'
Autor:
Lucia Macken, Louise Mason, Catherine Evans, Heather Gage, Jake Jordan, Mark Austin, Nick Parnell, Max Cooper, Shani Steer, Justine Boles, Stephen Bremner, Debbie Lambert, David Crook, Gemma Earl, Jean Timeyin, Sumita Verma
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-15 (2018)
Abstract Background UK deaths due to chronic liver diseases such as cirrhosis have quadrupled over the last 40 years, making this condition now the third most common cause of premature death. Most patients with advanced cirrhosis (end-stage liver dis
Externí odkaz:
https://doaj.org/article/3441c3603f4b47c3b0b45f65cd81be1c
Autor:
Lucia Macken, Louise Mason, Catherine Evans, Heather Gage, Jake Jordan, Mark Austin, Nick Parnell, Max Cooper, Shani Steer, Justine Boles, Stephen Bremner, Debbie Lambert, David Crook, Gemma Earl, Jean Timeyin, Sumita Verma
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-2 (2018)
Following publication of the original article [1], the authors reported that the figure legend for Figure 3 was absent. In addition, they have requested additional funding information to be added. In this Correction the initial and updated funding in
Externí odkaz:
https://doaj.org/article/795d2e537be34cbfb8cb6159f1d8234b
Autor:
Jake Jordan, Shani Steer, Morro Touray, Nick Parnell, Sumita Verma, Debbie Lambert, Sam Thomson, Heather Gage, Jean Timeyin, Lucia Macken, Mark Austin, Stephen Bremner, Mark Wright, Catherine J Evans, Max Cooper, Peter Isaacs, Ahmed Hashim, Louise Mason, Justine Boles, David Crook, David Sheridan, Gemma Earl
Publikováno v:
Posters.
Introduction Ascites develops in about 90% with advanced cirrhosis; when refractory to medical therapy, standard of care is repeated large volume paracentesis (LVP) with albumin support. Refractory ascites (RA) confers a median life expectancy of six
Autor:
Mark Austin, Stephen Bremner, Catherine J Evans, Heather Gage, Louise Mason, Max Cooper, Sumita Verma, Nick Parnell, Shani Steer, Gemma Earl, Jean Timeyin, Debbie Lambert, David Crook, Jake Jordan, Lucia Macken, Justine Boles
Publikováno v:
Trials
Trials, Vol 19, Iss 1, Pp 1-2 (2018)
Trials, Vol 19, Iss 1, Pp 1-2 (2018)
Background UK deaths due to chronic liver diseases such as cirrhosis have quadrupled over the last 40 years, making this condition now the third most common cause of premature death. Most patients with advanced cirrhosis (end-stage liver disease [ESL
Autor:
Mark Austin, Stephen Bremner, Catherine J Evans, Sumita Verma, Gemma Earl, Jake Jordan, Max Cooper, Heather Gage, Louise Mason, Lucia Macken, Nick Parnell, Shani Steer, Jean Timeyin, Justine Boles, Debbie Lambert, David Crook
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-15 (2018)
Background UK deaths due to chronic liver diseases such as cirrhosis have quadrupled over the last 40 years, making this condition now the third most common cause of premature death. Most patients with advanced cirrhosis (end-stage liver disease [ESL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91b00923a70f7632b123d49f40e93144
http://sro.sussex.ac.uk/id/eprint/76821/5/s13063-018-2779-0.pdf
http://sro.sussex.ac.uk/id/eprint/76821/5/s13063-018-2779-0.pdf
Autor:
Nicholas I, Paton, Cissy, Kityo, Anne, Hoppe, Andrew, Reid, Andrew, Kambugu, Abbas, Lugemwa, Joep J, van Oosterhout, Mary, Kiconco, Abraham, Siika, Raymond, Mwebaze, Mary, Abwola, George, Abongomera, Aggrey, Mweemba, Hillary, Alima, Dickens, Atwongyeire, Rose, Nyirenda, Justine, Boles, Jennifer, Thompson, Dinah, Tumukunde, Ennie, Chidziva, Ivan, Mambule, Jose R, Arribas, Philippa J, Easterbrook, James, Hakim, A Sarah, Walker, Peter, Mugyenyi, J, Villacian
Publikováno v:
The New England journal of medicine. 371(3)
BACKGROUND: The efficacy and toxic effects of nucleoside reverse-transcriptase inhibitors (NRTIs) are uncertain when these agents are used with a protease inhibitor in second-line therapy for human immunodeficiency virus (HIV) infection in resource-l
Publikováno v:
Journal of Investigative Dermatology. (10):2457-2462
We lack comparative data on sunscreens with comparable sun protection factors (SPFs), but with different levels of UVA protection, especially against cumulative erythema from repeated suberythemal exposure. Thus, we compared the protection from cumul